Clinical trials
Musculoskeletal Diseases or Conditions clinical trials
Below are recruiting musculoskeletal diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,020 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07431840Recruiting
Immune protein for respiratory infections in older adults
This trial tests whether an immune defense protein can help reduce upper respiratory infections (like colds) in people aged 60 and older. It may be a good fit if you get colds or flu-like symptoms several times each season.
Los Angeles, CaliforniaAges 60 years+ - NCT07432867RecruitingPhase 1/Phase 2
Gene therapy for severe sickle cell disease in teens and adults
This trial tests a new gene therapy for sickle cell disease. It uses your own blood stem cells (collected from bone marrow) that are modified in a lab to help produce healthy red blood cells, then given back to you after a short chemotherapy. The goal is to reduce or stop severe complications like pain crises and lung problems.
Paris, Île-de-France RegionAges 12–35 - NCT07436195Recruiting
Epigenetics and cell-free DNA in gestational diabetes study
This study looks at how changes in DNA (called epigenetics) might affect gestational diabetes in pregnancy. It aims to understand these changes using cell-free DNA from the mother and father.
Ulm, Baden-WurttembergAges 18 years+ - NCT07439848RecruitingPhase 1/Phase 2
Stem cells for severe lung injury from sepsis
This trial tests if adding stem cells or their growth liquid to standard sepsis treatment helps adults with severe breathing problems. It may improve recovery for those whose family agrees to the study.
Jakarta Pusat, DKI JakartaAges 40 years+ - NCT07441226RecruitingPhase 2
Stem cells for advanced COPD treatment
This trial tests whether adding umbilical cord stem cells to standard triple therapy can help people with Group E COPD. It aims to see if this approach improves lung function and quality of life.
Jakarta, Jakarta Special Capital RegionAges 40–75 - NCT07441525RecruitingEarly Phase 1
CAR-T cell therapy for hard-to-treat autoimmune blood diseases
This early-stage trial tests a new type of immune cell therapy (CAR-T) that targets two proteins, CD19 and BCMA, in people with autoimmune blood diseases like ITP, AIHA, or Evans syndrome that have not responded to standard treatments. It aims to reset the immune system and reduce production of harmful antibodies.
Wuhan, HubeiAges 18–75 - NCT07441993RecruitingPhase 2
Orelabrutinib for early-stage untreated marginal zone lymphoma
This trial tests an oral targeted therapy (orelabrutinib) for people with early-stage marginal zone lymphoma who have not yet had treatment. The goal is to see if this medication can control the cancer with fewer side effects than standard treatments.
Guangzhou, GuangdongAges 18 years+ - NCT07443943RecruitingPhase 2
Potato starch supplement for joint pain from hormone therapy
This trial studies whether a dietary supplement made from resistant potato starch can help reduce joint and muscle pain in people who are about to start aromatase inhibitor therapy for breast cancer or high risk. You take the supplement daily and report how you feel over 24 weeks.
Ann Arbor, MichiganAges Any age - NCT07444138Recruiting
Beetroot extract for blood pressure and exercise in older women
This study tests whether drinking beetroot extract can help lower blood pressure and improve exercise ability in older women with high blood pressure. It compares beetroot extract to a placebo (a drink with no active ingredient) while participants do light physical activities.
Bauru, São PauloAges 60 years+ - NCT07444723RecruitingPhase 2/Phase 3
New imaging to find parathyroid tumors before surgery
This study tests two advanced imaging techniques (PET/MR and PET/CT) to find overactive parathyroid glands or tumors that need surgery. Participants get a special scan before surgery to help surgeons locate the problem more accurately.
Bethesda, MarylandAges 18–100 - NCT07444931Recruiting
Predicting cardiac arrest risk in heart disease patients
This study looks at factors that may help predict sudden cardiac arrest in people with coronary artery disease. If you have a recent diagnosis of significant blockage or a heart attack, joining this trial could help improve risk assessment.
HaderaAges 18–75 - NCT07447869RecruitingEarly Phase 1
Lymph Node Exam in Cat Allergy Treatment Study
This study looks at lymph nodes in the neck to understand how the body responds to cat allergy treatments. It may help researchers improve allergy shots or other therapies for people with cat allergies.
Boston, MassachusettsAges 18–45 - NCT07448896Recruiting
Studying immune cells in stomach tissue after weight loss surgery
This study looks at how certain immune cells (mast cells and macrophages) and small blood vessels change in the stomach tissue of people who have weight loss surgery. It may help researchers better understand how the body responds to surgery and weight loss.
Alexandria, Alexandria GovernorateAges Any age - NCT07449130Recruiting
AI screening for valve disease using chest CT scans
This study uses a computer AI to look at routine chest CT scans and find people who might have valvular heart disease (problems with the heart's valves). It aims to see if AI can help catch these issues early, so you can get the right care sooner.
Wuhan, HubeiAges 18 years+ - NCT07450690Recruiting
Exercise training for muscle function in mitochondrial myopathy
This study tests whether exercise training can improve muscle function in adults with mitochondrial myopathy, a condition that affects how muscles produce energy. Participants will follow an exercise program to see if it helps their muscle strength and daily activities.
CopenhagenAges 18 years+ - NCT07451522Recruiting
Comparing pain relief methods after heart bypass surgery
This study compares different ways to manage pain after coronary artery bypass grafting (CABG), which is heart bypass surgery. The goal is to find which approach works best and is safest for patients in the early recovery period.
Vladivostok, Outside USAges 18–75 - NCT07454226Recruiting
Drug combo for Ph-like acute lymphoblastic leukemia
This trial tests a combination of targeted drugs (ABL/JAK inhibitors) with chemotherapy and venetoclax for people with a type of leukemia called Ph-like ALL. It aims to see if this treatment is safe and effective.
Tianjin, Tianjin MunicipalityAges 14–60 - NCT07461116Recruiting
Side effects of ATG/ALG treatment for aplastic anemia
This study looks at the side effects of a medicine called ATG or ALG, which is given to calm the immune system in people with aplastic anemia. It may help doctors better understand and manage these side effects.
TianjinAges Any age - NCT07462195RecruitingPhase 4
Dexmedetomidine for smoother recovery after thyroid surgery
This trial tests whether adding a medicine called dexmedetomidine during thyroid surgery helps you wake up more calmly and comfortably. It may reduce side effects like confusion or shakiness after anesthesia.
HanoiAges 18–65 - NCT07462780RecruitingPhase 1
Testing CMS-D017 in Healthy Volunteers
This trial tests a new investigational drug called CMS-D017 in healthy volunteers. Researchers will give single and multiple doses to see how the body processes it and if it's safe. You could help find an important new treatment.
BeijingAges 18–55 - NCT07468383Recruiting
Catheter ablation for slow heart rate study
This study tests a catheter procedure to treat a slow heart rate (bradycardia) that causes symptoms like dizziness or fainting. It may be an option for people who haven't had a pacemaker and whose heart can still speed up with medication.
Beijing, ChinaAges 18–65 - NCT07468604RecruitingPhase 4
Nerve block for long COVID
This study tests if a nerve block injection in the neck (stellate ganglion block) can help relieve long COVID symptoms related to your body's automatic functions, like dizziness, sweating, or digestion. It is for people who have had these symptoms for at least 3 months and are on stable medications.
Toronto, OntarioAges 18 years+ - NCT07470151Recruiting
Study of EVM18001 for hard-to-treat autoimmune diseases
This trial tests a new treatment, EVM18001, for people with lupus, myasthenia gravis, or systemic sclerosis that hasn't improved with standard therapies. It aims to see if this therapy can help control the disease.
Wuhan, HubeiAges 18–70 - NCT07470320Recruiting
Placenta study in healthy and complicated pregnancies
This study looks at how the placenta works in healthy pregnancies and in pregnancies with conditions like pre-eclampsia, gestational diabetes, or fetal growth restriction. It may help find new ways to detect or treat these problems.
OxfordAges 18 years+
Hear when a new Musculoskeletal Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for musculoskeletal diseases or conditions?
- Yes. Clin2 currently lists 4,020 recruiting musculoskeletal diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a musculoskeletal diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a musculoskeletal diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.